 | SWG | Name: | 2-[(4Z)-2-[(1R)-1-amino-2-hydroxy-ethyl]-4-(1H-indol-3-ylmethylidene)-5-oxo-imidazol-1-yl]ethanoic acid | Formula: | C16 H16 N4 O4 | SMILES: | N[CH](CO)C1=NC(=Cc2c[nH]c3ccccc23)C(=O)N1CC(O)=O | InChi: | InChI=1S/C16H16N4O4/c17-11(8-21)15-19-13(16(24)20(15)7-14(22)23)5-9-6-18-12-4-2-1-3-10(9)12/h1-6,11,18,21H,7-8,17H2,(H,22,23)/b13-5-/t11-/m0/s1 | Definition date: | 2011-03-25 | Last modified: | 2024-09-27 | Identifier: | 2-[(4Z)-2-[(1R)-1-amino-2-hydroxy-ethyl]-4-(1H-indol-3-ylmethylidene)-5-oxo-imidazol-1-yl]ethanoic acid |
|
 | VPV | Name: | (2E,4R)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid | Formula: | C13 H22 N2 O7 | SMILES: | C(=O)(O)C(N)CCCC/N=C(/C(O)=O)CC(CCC(=O)O)O | InChi: | InChI=1S/C13H22N2O7/c14-9(12(19)20)3-1-2-6-15-10(13(21)22)7-8(16)4-5-11(17)18/h8-9,16H,1-7,14H2,(H,17,18)(H,19,20)(H,21,22)/b15-10+/t8-,9+/m1/s1 | Definition date: | 2020-09-02 | Last modified: | 2024-09-27 | Release date: | 2021-09-22 | Identifier: | (2E,4R)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid |
|
 | NLM | Name: | 4-[(3-chloropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C11 H9 Cl N2 O5 S2 | SMILES: | N(S(c1ccc(cc1)S(=O)(=O)O)(=O)=O)c2ncccc2Cl | InChi: | InChI=1S/C11H9ClN2O5S2/c12-10-2-1-7-13-11(10)14-20(15,16)8-3-5-9(6-4-8)21(17,18)19/h1-7H,(H,13,14)(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(3-chloropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid |
|
 | U4L | Name: | (4P)-4-(5-methyl-1H-indazol-4-yl)-6-(2-propanoyl-2,6-diazaspiro[3.4]octan-6-yl)-2-(pyrrolidin-1-yl)pyrimidine-5-carbonitrile | Formula: | C26 H30 N8 O | SMILES: | CCC(=O)N1CC2(CCN(C2)c2nc(nc(c3c(C)ccc4[NH]ncc34)c2C#N)N2CCCC2)C1 | InChi: | InChI=1S/C26H30N8O/c1-3-21(35)34-15-26(16-34)8-11-33(14-26)24-18(12-27)23(29-25(30-24)32-9-4-5-10-32)22-17(2)6-7-20-19(22)13-28-31-20/h6-7,13H,3-5,8-11,14-16H2,1-2H3,(H,28,31) | Definition date: | 2022-08-04 | Last modified: | 2024-09-27 | Release date: | 2022-08-17 | Identifier: | (4P)-4-(5-methyl-1H-indazol-4-yl)-6-(2-propanoyl-2,6-diazaspiro[3.4]octan-6-yl)-2-(pyrrolidin-1-yl)pyrimidine-5-carbonitrile |
|
 | XDV | Name: | 2-[2-(2-aminoethoxy)ethoxy]acetamide | Formula: | C6 H14 N2 O3 | SMILES: | NC(COCCOCCN)=O | InChi: | InChI=1S/C6H14N2O3/c7-1-2-10-3-4-11-5-6(8)9/h1-5,7H2,(H2,8,9) | Definition date: | 2020-12-11 | Last modified: | 2024-09-27 | Release date: | 2020-12-23 | Identifier: | 2-[2-(2-aminoethoxy)ethoxy]acetamide |
|
 | SWH | Name: | {4-[(4-{(Z)-[3-(4-FLUOROBENZYL)-2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}PHENOXY)METHYL]PHENYL}(TRIHYDROXY)BORATE(1-) | Formula: | C24 H20 B F N O6 S | SMILES: | O=C1S/C(C(=O)N1Cc2ccc(F)cc2)=Cc4ccc(OCc3ccc(cc3)[B-](O)(O)O)cc4 | InChi: | InChI=1S/C24H20BFNO6S/c26-20-9-3-17(4-10-20)14-27-23(28)22(34-24(27)29)13-16-5-11-21(12-6-16)33-15-18-1-7-19(8-2-18)25(30,31)32/h1-13,30-32H,14-15H2/q-1/b22-13- | Synonyms: | HA155 INHIBITOR | Definition date: | 2010-09-14 | Last modified: | 2024-09-27 | Identifier: | {4-[(4-{(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenoxy)methyl]phenyl}(trihydroxy)borate(1-) |
|
 | YJ2 | Name: | (2S,4R)-1-[1-(4-BROMOPHENYL)CYCLOPROPYL]CARBONYL-4-(2-CHLOROPHENYL)SULFONYL-N-[1-(IMINOMETHYL)CYCLOPROPYL]PYRROLIDINE-2-CARBOXAMIDE | Formula: | C25 H25 Br Cl N3 O4 S | SMILES: | O=S(=O)(c1ccccc1Cl)C5CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C4(c3ccc(Br)cc3)CC4)C5 | InChi: | InChI=1S/C25H25BrClN3O4S/c26-17-7-5-16(6-8-17)25(11-12-25)23(32)30-14-18(35(33,34)21-4-2-1-3-19(21)27)13-20(30)22(31)29-24(15-28)9-10-24/h1-8,15,18,20,28H,9-14H2,(H,29,31)/b28-15+/t18-,20+/m1/s1 | Definition date: | 2011-05-18 | Last modified: | 2024-09-27 | Identifier: | (4R)-1-{[1-(4-bromophenyl)cyclopropyl]carbonyl}-4-[(2-chlorophenyl)sulfonyl]-N-[1-(iminomethyl)cyclopropyl]-L-prolinamide |
|
 | Y5S | Name: | (1S,2S)-2-((S)-2-(((((1R,3s,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | Formula: | C24 H41 N3 O8 S | SMILES: | CC(CC(C(=O)NC(C(O)S(=O)(=O)O)CC1CCNC1=O)NC(OCC3CC2CCCC(C2)C3)=O)C | InChi: | InChI=1S/C24H41N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h14-20,23,30H,3-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19-,20-,23-/m0/s1 | Definition date: | 2021-02-04 | Last modified: | 2024-09-27 | Release date: | 2021-02-17 | Identifier: | (1S,2S)-2-{[N-({[(3-endo)-bicyclo[3.3.1]nonan-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | UVN | Name: | 4-(3-oxidanylidenepiperazin-1-yl)sulfonylbenzaldehyde | Formula: | C11 H12 N2 O4 S | SMILES: | O=Cc1ccc(cc1)[S](=O)(=O)N2CCNC(=O)C2 | InChi: | InChI=1S/C11H12N2O4S/c14-8-9-1-3-10(4-2-9)18(16,17)13-6-5-12-11(15)7-13/h1-4,8H,5-7H2,(H,12,15) | Definition date: | 2021-03-23 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-(3-oxidanylidenepiperazin-1-yl)sulfonylbenzaldehyde |
|
 | POA | Name: | PHOSPHONOACETALDEHYDE | Formula: | C2 H5 O4 P | SMILES: | O=CCP(=O)(O)O | InChi: | InChI=1S/C2H5O4P/c3-1-2-7(4,5)6/h1H,2H2,(H2,4,5,6) | Definition date: | 2002-07-12 | Last modified: | 2024-09-27 | Identifier: | (2-oxoethyl)phosphonic acid |
|
 | NLN | Name: | NORLEUCINE AMIDE | Formula: | C6 H14 N2 O | SMILES: | O=C(N)C(N)CCCC | InChi: | InChI=1S/C6H14N2O/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H2,8,9)/t5-/m0/s1 | Synonyms: | 2-AMINO-HEXANOIC ACID AMIDE | Definition date: | 2000-02-02 | Last modified: | 2024-09-27 | Identifier: | L-norleucinamide |
|
 | NLO | Name: | O-METHYL-L-NORLEUCINE | Formula: | C7 H15 N O2 | SMILES: | O=C(OC)C(N)CCCC | InChi: | InChI=1S/C7H15NO2/c1-3-4-5-6(8)7(9)10-2/h6H,3-5,8H2,1-2H3/t6-/m0/s1 | Definition date: | 2004-01-27 | Last modified: | 2024-09-27 | Identifier: | methyl L-norleucinate |
|
 | ZKO | Name: | N-SUCCINYL-GLUTAMINE | Formula: | C9 H14 N2 O6 | SMILES: | NC(=O)CC[CH](NC(=O)CCC(O)=O)C(O)=O | InChi: | InChI=1S/C9H14N2O6/c10-6(12)2-1-5(9(16)17)11-7(13)3-4-8(14)15/h5H,1-4H2,(H2,10,12)(H,11,13)(H,14,15)(H,16,17)/t5-/m0/s1 | Synonyms: | 5-azanyl-5-oxidanylidene-2-[(4-oxidanyl-4-oxidanylidene-butanoyl)amino]pentanoic acid | Definition date: | 2024-01-22 | Last modified: | 2024-09-27 | Release date: | 2024-04-24 | Identifier: | 5-azanyl-5-oxidanylidene-2-[(4-oxidanyl-4-oxidanylidene-butanoyl)amino]pentanoic acid |
|
 | KDP | Name: | 2-KETO-DEOXY-GALACTOSE | Formula: | C6 H11 O9 P | SMILES: | O=P(O)(O)OCC(O)C(O)CC(=O)C(=O)O | InChi: | InChI=1S/C6H11O9P/c7-3(1-4(8)6(10)11)5(9)2-15-16(12,13)14/h3,5,7,9H,1-2H2,(H,10,11)(H2,12,13,14)/t3-,5-/m1/s1 | Definition date: | 2007-08-02 | Last modified: | 2024-09-27 | Identifier: | 3-deoxy-6-O-phosphono-D-threo-hex-2-ulosonic acid |
|
 | N7P | Name: | 1-ACETYL-L-PROLINE | Formula: | C7 H11 N O3 | SMILES: | OC(=O)C1N(C(=O)C)CCC1 | InChi: | InChI=1S/C7H11NO3/c1-5(9)8-4-2-3-6(8)7(10)11/h6H,2-4H2,1H3,(H,10,11)/t6-/m0/s1 | Synonyms: | N-ACETYLPROLINE | Definition date: | 2003-02-21 | Last modified: | 2024-09-27 | Identifier: | 1-acetyl-L-proline |
|
 | XDY | Name: | N-[(1S,2S)-2-aminocyclopentyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C14 H20 N4 O5 | SMILES: | C(CN(C1C(N)CCC1)C(=O)CN2C(NC(=O)C(C)=C2)=O)(O)=O | InChi: | InChI=1S/C14H20N4O5/c1-8-5-17(14(23)16-13(8)22)6-11(19)18(7-12(20)21)10-4-2-3-9(10)15/h5,9-10H,2-4,6-7,15H2,1H3,(H,20,21)(H,16,22,23)/t9-,10-/m0/s1 | Definition date: | 2020-12-11 | Last modified: | 2024-09-27 | Release date: | 2020-12-23 | Identifier: | N-[(1S,2S)-2-aminocyclopentyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
 | 4C9 | Name: | (2S)-2-({(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}carbonyl)-4,4-dimethylpentanenitrile | Formula: | C30 H33 N7 O2 | SMILES: | N#CC(C(=O)N5CCCC(n2nc(c1c(ncnc12)N)c4ccc(Oc3ccccc3)cc4)C5)CC(C)(C)C | InChi: | InChI=1S/C30H33N7O2/c1-30(2,3)16-21(17-31)29(38)36-15-7-8-22(18-36)37-28-25(27(32)33-19-34-28)26(35-37)20-11-13-24(14-12-20)39-23-9-5-4-6-10-23/h4-6,9-14,19,21-22H,7-8,15-16,18H2,1-3H3,(H2,32,33,34)/t21-,22-/m1/s1 | Definition date: | 2015-02-27 | Last modified: | 2024-09-27 | Release date: | 2015-05-13 | Identifier: | (2S)-2-({(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}carbonyl)-4,4-dimethylpentanenitrile |
|
 | ROJ | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{R},4~{R})-4-chloranyl-3-oxidanyl-oxolan-2-yl]methyl hydrogen phosphate | Formula: | C15 H22 Cl N5 O12 P2 | SMILES: | C1(COC(C1O)COP(OP(O)(=O)OCC2C(C(C(O2)n3c4c(nc3)c(N)ncn4)O)O)(=O)O)Cl | InChi: | InChI=1S/C15H22ClN5O12P2/c16-6-1-29-7(10(6)22)2-30-34(25,26)33-35(27,28)31-3-8-11(23)12(24)15(32-8)21-5-20-9-13(17)18-4-19-14(9)21/h4-8,10-12,15,22-24H,1-3H2,(H,25,26)(H,27,28)(H2,17,18,19)/t6-,7-,8-,10+,11-,12-,15-/m1/s1 | Definition date: | 2020-02-18 | Last modified: | 2024-09-27 | Release date: | 2020-06-03 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3R,4R)-4-chloro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
 | XSA | Name: | (2R)-2-[(2-aminoethyl)amino]-4-boronobutanoic acid | Formula: | C6 H15 B N2 O4 | SMILES: | C(C(O)=O)(NCCN)CCB(O)O | InChi: | InChI=1S/C6H15BN2O4/c8-3-4-9-5(6(10)11)1-2-7(12)13/h5,9,12-13H,1-4,8H2,(H,10,11)/t5-/m1/s1 | Definition date: | 2021-01-08 | Last modified: | 2024-09-27 | Release date: | 2022-02-09 | Identifier: | (2R)-2-[(2-aminoethyl)amino]-4-boronobutanoic acid |
|
 | UVQ | Name: | 4-[(6-fluoranyl-3,4-dihydro-2~{H}-quinolin-1-yl)sulfonyl]benzaldehyde | Formula: | C16 H14 F N O3 S | SMILES: | Fc1ccc2N(CCCc2c1)[S](=O)(=O)c3ccc(C=O)cc3 | InChi: | InChI=1S/C16H14FNO3S/c17-14-5-8-16-13(10-14)2-1-9-18(16)22(20,21)15-6-3-12(11-19)4-7-15/h3-8,10-11H,1-2,9H2 | Definition date: | 2021-03-23 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-[(6-fluoranyl-3,4-dihydro-2~{H}-quinolin-1-yl)sulfonyl]benzaldehyde |
|
 | NLS | Name: | 4-[(6-fluoropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid | Formula: | C11 H9 F N2 O5 S2 | SMILES: | N(c1nc(F)ccc1)S(c2ccc(S(=O)(=O)O)cc2)(=O)=O | InChi: | InChI=1S/C11H9FN2O5S2/c12-10-2-1-3-11(13-10)14-20(15,16)8-4-6-9(7-5-8)21(17,18)19/h1-7H,(H,13,14)(H,17,18,19) | Definition date: | 2019-05-20 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | 4-[(6-fluoropyridin-2-yl)sulfamoyl]benzene-1-sulfonic acid |
|
 | Y5X | Name: | 2-chloro-N-(5-fluoropyridin-3-yl)-5-nitrobenzamide | Formula: | C12 H7 Cl F N3 O3 | SMILES: | O=C(Nc1cc(F)cnc1)c1cc(ccc1Cl)[N+]([O-])=O | InChi: | InChI=1S/C12H7ClFN3O3/c13-11-2-1-9(17(19)20)4-10(11)12(18)16-8-3-7(14)5-15-6-8/h1-6H,(H,16,18) | Definition date: | 2023-01-05 | Last modified: | 2024-09-27 | Release date: | 2024-04-17 | Identifier: | 2-chloro-N-(5-fluoropyridin-3-yl)-5-nitrobenzamide |
|
 | ZKR | Name: | [5-(trifluoromethyl)thiophen-2-yl]boronic acid | Formula: | C5 H4 B F3 O2 S | SMILES: | FC(F)(F)c1ccc(s1)B(O)O | InChi: | InChI=1S/C5H4BF3O2S/c7-5(8,9)3-1-2-4(12-3)6(10)11/h1-2,10-11H | Definition date: | 2023-06-28 | Last modified: | 2024-09-27 | Release date: | 2024-07-17 | Identifier: | [5-(trifluoromethyl)thiophen-2-yl]boronic acid |
|
 | UI5 | Name: | (1~{S},2~{S},3~{S},4~{R})-4-azanyl-3-(hydroxymethyl)cyclopentane-1,2-diol | Formula: | C6 H13 N O3 | SMILES: | N[CH]1C[CH](O)[CH](O)[CH]1CO | InChi: | InChI=1S/C6H13NO3/c7-4-1-5(9)6(10)3(4)2-8/h3-6,8-10H,1-2,7H2/t3-,4-,5+,6+/m1/s1 | Definition date: | 2023-09-05 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | (1~{S},2~{S},3~{S},4~{R})-4-azanyl-3-(hydroxymethyl)cyclopentane-1,2-diol |
|
 | UVT | Name: | 4-[(2~{S})-2-methylpyrrolidin-1-yl]sulfonylbenzaldehyde | Formula: | C12 H15 N O3 S | SMILES: | C[CH]1CCCN1[S](=O)(=O)c2ccc(C=O)cc2 | InChi: | InChI=1S/C12H15NO3S/c1-10-3-2-8-13(10)17(15,16)12-6-4-11(9-14)5-7-12/h4-7,9-10H,2-3,8H2,1H3/t10-/m0/s1 | Definition date: | 2021-03-23 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-[(2~{S})-2-methylpyrrolidin-1-yl]sulfonylbenzaldehyde |
|